K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratificationAndrew S. Levey, Antonio M. Gotto, Josef Coresh et al.|Data Archiving and Networked Services (DANS)|2002Cited by 11.7k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyVlado Perkovic, Kenneth W. Mahaffey, Meg Jardine et al.|New England Journal of Medicine|2019Cited by 6k
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and StratificationAndrew S. Levey, Garabed Eknoyan, Josef Coresh et al.|Annals of Internal Medicine|2003Cited by 4.6k
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Andrew S. Levey, Garabed Eknoyan, Yusuke Tsukamoto et al.|Kidney International|2005Cited by 3.9k
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global OutcomesAndrew S. Levey, Garabed Eknoyan, R. C. Atkins et al.|Kidney International|2007Cited by 1.5k